FDA Opposes COVID-19 Vaccination Dose and Schedule Changes to Vaccinate More People
Only two weeks after the first experimental biologic for SARS-CoV-2 became available, the U.S. was more than 16 millions doses behind Operation Warp Speed’s goal of giving COVID-19 vaccines to 20 million people by the end of 2020.1 Responding to the slow rollout, Operation Warp Speed chief adviser Moncef Slaoui, MD proposed giving half-doses to […]
Miami Obstetrician Develops Bleeding Disorder, Dies After Getting COVID-19 Vaccine
Gregory Michael, MD, an obstetrician in private practice at Mount Sinai Medical Center in Miami Beach received a first dose of the Pfizer/BioNTech experimental mRNA COVID-19 vaccine on Dec. 18 and died 16 days later of a cerebral hemorrhage (stroke).1 Within three days of taking the shot, he developed symptoms of a severe autoimmune bleeding […]
60 Percent of Nursing Home Workers in Ohio Decline COVID-19 Vaccines Over Safety Concerns
In a news briefing on Dec. 30, 2020, Ohio’s Governor Mike DeWine said that 60 percent of the nursing home staff in his state are refusing to get COVID-19 vaccines. According to surveys, health care workers in the United States have expressed fears of potentially dangerous side effects from the experimental vaccines and concerns about […]
Over 3,000 “Health Impact Events” After COVID-19 mRNA Vaccinations
Between Dec. 11 and 18, 2020, the U.S. Food and Drug Administration (FDA) granted Pfizer/BioNTech and Moderna pharmaceutical companies an Emergency Use Authorization (EUA)1 to distribute COVID-19 vaccines using messenger RNA (mRNA) technology that to date has not been licensed for use in humans.2 3 4 5 Although the Advisory Committee on Immunization Practices (ACIP) […]
Severe Allergic Reactions Reported After Pfizer/BioNTech COVID-19 Vaccinations
Last week the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) issued a strong warning to those who have a history of significant allergic reactions to medicines, foods or vaccines or who carry an epi-pen that they may be at increased individual risk for suffering a serious allergic reaction after receiving the Pfizer/BioNTech COVID-19 […]
Brazil Halts and Re-Starts Phase 3 Clinical Trials of Chinese COVID-19 Vaccine
Brazil briefly stopped clinical trials of CoronaVac, the Chinese-made experimental vaccine for COVID-19, after a death among trial participants was reported on Nov 9, 2020. The Bhutantan Institute in San Paulo, Brazil had been conducting Phase 3 trials with more than 10,000 volunteers when the study was halted.1 However, within days, Bhutantan officials announced they […]